"
Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4"
written by M. Said, M. S. El-Raziky, M. Abdel-Hamid, Y. Saad, M. Hashem, S. Zakaria, M. K. Mohamed, G. Esmat,
published by
Open Journal of Internal Medicine,
Vol.1 No.2, 2011
has been cited by the following article(s):
[1]
|
Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients
Microbial Pathogenesis,
2021
DOI:10.1016/j.micpath.2021.104740
|
|
|
[2]
|
Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients
Microbial Pathogenesis,
2021
DOI:10.1016/j.micpath.2021.104740
|
|
|
[3]
|
New and Efficient Synthesis of HCV NS3/4 A Protease Inhibitor Telaprevir
ChemistrySelect,
2019
DOI:10.1002/slct.201902078
|
|
|
[4]
|
New and Efficient Synthesis of HCV NS3/4 A Protease Inhibitor Telaprevir
ChemistrySelect,
2019
DOI:10.1002/slct.201902078
|
|
|